CyTOF panel for the phenotypic and functional analysis of immune cell subsets
Metal label | Specificity | Antibody clone | |
---|---|---|---|
1 | 115In | Dead cells | n/a |
2 | 140Ce | Beads | n/a |
3 | 141Pr | CD25 | M-A251 |
4 | 142Nd | CD19 | HIB19 |
5 | 143Nd | IL-10 | JES3-9D7 |
6 | 144Nd | IL-4 | MP4-25D2 |
7 | 145Nd | CD4 | RPA-T4 |
8 | 146Nd | CD8 | RPA-T8 |
9 | 147Sm | CD20 | 2H7 |
10 | 148Nd | CD57 | HCD57 |
11 | 149Sm | CTLA-4 | 14D3 |
12 | 150Nd | MIP-1β | D21–1351 |
13 | 151Eu | CD107a | H4A3 |
14 | 152Sm | TNFa | Mab11 |
15 | 153Eu | CD45RA | HI100 |
16 | 154Sm | CD3 | UCHT1 |
17 | 155Gd | CD28 | L293 |
18 | 156Gd | CD38 | HB-7 |
19 | 157Gd | HLA-DR | G46–6 |
20 | 158Gd | CD33 | WM53 |
21 | 159 Tb | GMCSF | BVD2-21C11 |
22 | 160Gd | CD14 | M5E2 |
23 | 161Dy | IFNγ | 4S.B3 |
24 | 162Dy | CD69 | FN50 |
25 | 163Dy | TCRγδ | B1 |
26 | 164Dy | IL-17 | N49–853 |
27 | 165Ho | CD127 | A019D5 |
28 | 166Er | IL-2 | MQ1-17 h12 |
29 | 167Er | CD27 | L128 |
30 | 168Er | CD154 (CD40L) | 24–31 |
31 | 169Tm | CCR7 | 150503 |
32 | 170Er | PD1 | EH12.1 |
33 | 171Yb | Granzyme B | GB11 |
34 | 172Yb | PD-L2 | 24F.10C12 |
35 | 173Yb | Perforin | B-D48 |
36 | 174Yb | CD16 | 3G8 |
37 | 175Lu | PD-L1 | 29E.2A3 |
38 | 176Yb | CD56 | NCAM16.2 |
39 | 191Ir | DNA1 | n/a |
40 | 193Ir | DNA2 | n/a |
A 40-marker CyTOF panel for the phenotypic and functional analysis of immune cell subsets in melanoma patients treated with anti-CTLA-4 or anti-PD-1 therapy is shown. The element and isotope of the metal tag conjugated to each antibody and non-protein subject (italic) is indicated under the ‘Metal Label’ column. ‘Specificity’ indicates the target recognized by the metal-conjugated antibody or non-protein subject. 193Ir/195Ir DNA Intercalator and 115In Maleimide DOTA live/dead stain facilitate the identification of live intact singlets while calibration beads (140Ce) are important for data pre-processing. Antibody clones are listed when applicable